Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Study ID: NCT07461675
Start Date: 2026-03-25
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

30

Intervention / Treatment

Atezolizumab

Sponsor

University of Geneva, Switzerland

Source: clinicaltrials.gov

Share:
Add to list

'Do Patient Characteristics Associate With Poor Outcome With FAIS Following Physiotherapy-led Rehabilitation'

Study ID: NCT07460401
Start Date: 2026-04-06
End Date: 2028-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

175

Intervention / Treatment

No intervention assigned. This is an observational study

Sponsor

University of Oxford

Source: clinicaltrials.gov

Share:
Add to list

Probiotic Improve Constipation

Study ID: NCT07462481
Start Date: 2026-04-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Probiotic

Placebo

Sponsor

Wecare Probiotics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

tDCS and Symptom Provocation in Treatment-Resistant OCD

Study ID: NCT07429500
Start Date: 2026-04-01
End Date: 2029-10-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

178

Intervention / Treatment

tDCS session

symptom provocation

Sponsor

Henri Laborit Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Study ID: NCT07468071
Start Date: 2026-06-24
End Date: 2029-09-25
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Opnurasib

TNO155

trametinib

cetuximab

tislelizumab

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Study ID: NCT07084584
Start Date: 2026-06-10
End Date: 2029-10-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

184

Intervention / Treatment

Gebaait

Sponsor

Galecto Biotech AB

Source: clinicaltrials.gov

Share:
Add to list

RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy

Study ID: NCT07467174
Start Date: 2026-04
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

538

Intervention / Treatment

conventional laparoscopy gastrectomy group (Port > 3)

reduced-port robotic group (Port ≤ 3)

Sponsor

Yonsei University

Source: clinicaltrials.gov

Share:
Add to list

Coronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients.

Study ID: NCT07140419
Start Date: 2026-04-01
End Date: 2032-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Coronary computed tomographic angiography with CT - derived fractional flow reserve

Sponsor

Qilu Hospital of Shandong University

Source: clinicaltrials.gov

Share:
Add to list

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

Study ID: NCT07454460
Start Date: 2026-04-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Asynchronous coaching and artificial intelligence (AI) Yoodli coach sessions

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Opti Gait Wearable Gait Tracker

Study ID: NCT07158580
Start Date: 2026-06
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Gait Tracker

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list